• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝癌的三重阳性肿瘤标志物是预测不良生存的有用指标。

Triple positive tumor markers for hepatocellular carcinoma are useful predictors of poor survival.

机构信息

Second Department of Surgery, Wakayama Medical University, School of Medicine, Wakayama, Japan.

出版信息

Ann Surg. 2011 Dec;254(6):984-91. doi: 10.1097/SLA.0b013e3182215016.

DOI:10.1097/SLA.0b013e3182215016
PMID:21606837
Abstract

OBJECTIVE

To determine the importance of the expression pattern of multiple tumor markers for hepatocellular carcinoma (HCC) with regard to the tumor malignancy and patient survival.

BACKGROUND

Several studies have indicated that HCC tumor markers, including alpha-fetoprotein (AFP), Lens culinaris agglutinin-reactive fraction of AFP and des-γ-carboxy prothrombin were predictors of HCC malignancy. However, few reports have shown the relevance of the expression pattern of these 3 tumor markers with regard to patient prognosis. We herein reported the influence of the expression pattern of these 3 tumor markers on HCC malignancy and patient prognosis.

METHODS

This retrospective study analyzed 185 patients who underwent hepatectomy for HCC between January 1999 and May 2009. The relationships between clinical parameters and these 3 tumor markers were analyzed. Cox proportional hazards regression analyses were performed to estimate risk factors for recurrence and survival. Furthermore, the relationships between pathological parameters and the expression patterns of the 3 tumor markers were analyzed.

RESULTS

From clinical parameters, expression patterns of 3 tumor markers were related to maximum tumor size and macrovascular invasion in image findings. Multivariate analyses revealed independent risk factors for recurrence or survival to be the Child-Pugh score, the presence of multiple tumors, and triple positive tumor marker expression. From pathological findings, microvascular invasion and an Edmondson-Steiner classification of III or IV were related to the expression patterns of the 3 tumor markers.

CONCLUSIONS

Triple positive tumor markers for HCC showed poor prognosis and invasive characteristics in pathological findings. Examination of these markers would be useful for predicting the degree of HCC malignancy.

摘要

目的

确定多种肿瘤标志物在肝癌(HCC)表达模式的重要性,特别是在肿瘤恶性程度和患者生存方面。

背景

多项研究表明,HCC 肿瘤标志物,包括甲胎蛋白(AFP)、扁豆凝集素结合 AFP 反应片段和去γ-羧基凝血酶原,是 HCC 恶性程度的预测因子。然而,很少有报道表明这 3 种肿瘤标志物表达模式与患者预后的相关性。我们在此报告了这 3 种肿瘤标志物表达模式对 HCC 恶性程度和患者预后的影响。

方法

本回顾性研究分析了 1999 年 1 月至 2009 年 5 月期间接受肝切除术治疗 HCC 的 185 例患者。分析了临床参数与这 3 种肿瘤标志物之间的关系。采用 Cox 比例风险回归分析来估计复发和生存的风险因素。此外,还分析了病理参数与 3 种肿瘤标志物表达模式之间的关系。

结果

从临床参数来看,3 种肿瘤标志物的表达模式与影像学检查中的最大肿瘤直径和大血管侵犯有关。多因素分析显示,复发或生存的独立风险因素为 Child-Pugh 评分、多发肿瘤和 3 种肿瘤标志物均阳性。从病理发现来看,微血管侵犯和 Edmondson-Steiner 分级为 III 或 IV 级与 3 种肿瘤标志物的表达模式有关。

结论

HCC 的 3 种肿瘤标志物均阳性提示预后不良,且具有侵袭性病理特征。这些标志物的检测有助于预测 HCC 的恶性程度。

相似文献

1
Triple positive tumor markers for hepatocellular carcinoma are useful predictors of poor survival.肝癌的三重阳性肿瘤标志物是预测不良生存的有用指标。
Ann Surg. 2011 Dec;254(6):984-91. doi: 10.1097/SLA.0b013e3182215016.
2
Prognostic value of pretreatment levels of tumor markers for hepatocellular carcinoma on survival after curative treatment of patients with HCC.肝癌患者根治性治疗后,肿瘤标志物预处理水平对肝细胞癌生存的预后价值。
J Hepatol. 2008 Aug;49(2):223-32. doi: 10.1016/j.jhep.2008.04.013. Epub 2008 May 23.
3
Staging hepatocellular carcinoma by a novel scoring system (BALAD score) based on serum markers.基于血清标志物的新型评分系统(BALAD评分)对肝细胞癌进行分期
Clin Gastroenterol Hepatol. 2006 Dec;4(12):1528-36. doi: 10.1016/j.cgh.2006.09.021.
4
Prognostic significance of a combination of pre- and post-treatment tumor markers for hepatocellular carcinoma curatively treated with hepatectomy.术前和术后肿瘤标志物联合对肝癌根治性切除术后的预后意义。
J Hepatol. 2012 Dec;57(6):1251-7. doi: 10.1016/j.jhep.2012.07.018. Epub 2012 Jul 20.
5
Clinicopathological risk factors for recurrence within one year after initial hepatectomy for hepatocellular carcinoma.肝细胞癌初次肝切除术后一年内复发的临床病理危险因素。
Am Surg. 2011 May;77(5):572-8.
6
Significance of alpha-fetoprotein and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma undergoing hepatectomy.甲胎蛋白和去γ-羧基凝血酶原在接受肝切除术的肝细胞癌患者中的意义。
Ann Surg Oncol. 2009 Oct;16(10):2795-804. doi: 10.1245/s10434-009-0618-y. Epub 2009 Aug 11.
7
Prognostic values of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II in hepatitis B virus-related hepatocellular carcinoma: a prospective study.甲胎蛋白及维生素K缺乏或拮抗剂-II诱导蛋白在乙型肝炎病毒相关肝细胞癌中的预后价值:一项前瞻性研究
J Clin Gastroenterol. 2009 May-Jun;43(5):482-8. doi: 10.1097/MCG.0b013e318182015a.
8
Prediction of recurrence of hepatocellular carcinoma after curative ablation using three tumor markers.使用三种肿瘤标志物预测根治性消融术后肝细胞癌的复发情况。
Hepatology. 2006 Dec;44(6):1518-27. doi: 10.1002/hep.21408.
9
Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein as a marker of prognosis and a monitor of recurrence of hepatocellular carcinoma after curative liver resection.甲胎蛋白 Lens culinaris agglutinin-reactive fraction 作为肝癌根治性切除术后预后和复发监测的标志物。
Ann Surg Oncol. 2011 Aug;18(8):2218-23. doi: 10.1245/s10434-011-1613-7. Epub 2011 Feb 20.
10
Time-dependent analysis of predisposing factors for the recurrence of hepatocellular carcinoma.肝癌复发相关因素的时间依赖性分析。
Liver Int. 2010 Aug;30(7):1027-32. doi: 10.1111/j.1478-3231.2010.02252.x. Epub 2010 May 18.

引用本文的文献

1
Chinese expert consensus on the diagnosis and treatment of hepatocellular carcinoma with microvascular invasion (2024 edition).肝细胞癌微血管侵犯诊断与治疗中国专家共识(2024年版)
Hepatobiliary Surg Nutr. 2025 Apr 1;14(2):246-266. doi: 10.21037/hbsn-24-359. Epub 2024 Dec 30.
2
Histone methyltransferase SUV420H1/KMT5B contributes to poor prognosis in hepatocellular carcinoma.组蛋白甲基转移酶 SUV420H1/KMT5B 促进肝癌不良预后。
Cancer Sci. 2024 Feb;115(2):385-400. doi: 10.1111/cas.16038. Epub 2023 Dec 11.
3
Usefulness of Tumor Marker Score for Predicting the Prognosis of Hepatocellular Carcinoma Patients Treated with Atezolizumab Plus Bevacizumab: A Multicenter Retrospective Study.
肿瘤标志物评分对预测接受阿替利珠单抗联合贝伐单抗治疗的肝细胞癌患者预后的价值:一项多中心回顾性研究
Cancers (Basel). 2023 Aug 31;15(17):4348. doi: 10.3390/cancers15174348.
4
Promising Novel Biomarkers for Hepatocellular Carcinoma: Diagnostic and Prognostic Insights.肝细胞癌有前景的新型生物标志物:诊断与预后见解
J Hepatocell Carcinoma. 2023 Jul 18;10:1105-1127. doi: 10.2147/JHC.S341195. eCollection 2023.
5
Prognostic Values of Alpha-Fetoprotein and Des-Gamma-Carboxyprothrombin in Hepatocellular Carcinoma in China: An Analysis of 4792 Patients.甲胎蛋白和异常凝血酶原在中国肝细胞癌中的预后价值:4792例患者分析
J Hepatocell Carcinoma. 2021 Jun 25;8:657-670. doi: 10.2147/JHC.S316223. eCollection 2021.
6
Biomarkers in Hepatocellular Carcinoma: Diagnosis, Prognosis and Treatment Response Assessment.肝细胞癌的生物标志物:诊断、预后和治疗反应评估。
Cells. 2020 Jun 1;9(6):1370. doi: 10.3390/cells9061370.
7
Validation of prognostic impact of ADV score for resection of hepatocellular carcinoma: analysis using Korea Liver Cancer Registry Database.ADV评分对肝细胞癌切除术预后影响的验证:基于韩国肝癌登记数据库的分析
Ann Surg Treat Res. 2020 May;98(5):235-246. doi: 10.4174/astr.2020.98.5.235. Epub 2020 Apr 28.
8
Daily decrease of post-operative alpha-fetoprotein by 9% discriminates prognosis of HCC: A multicenter retrospective study.术后甲胎蛋白每日下降9%可鉴别肝癌预后:一项多中心回顾性研究。
Aging (Albany NY). 2019 Dec 12;11(23):11111-11123. doi: 10.18632/aging.102513.
9
Prediction of Prognosis of Intermediate-Stage HCC Patients: Validation of the Tumor Marker Score in a Nationwide Database in Japan.中期肝癌患者预后的预测:日本全国数据库中肿瘤标志物评分的验证
Liver Cancer. 2019 Oct;8(5):403-411. doi: 10.1159/000495944. Epub 2019 Feb 18.
10
Multidisciplinary management of recurrent and metastatic hepatocellular carcinoma after resection: an international expert consensus.肝切除术后复发和转移性肝细胞癌的多学科管理:一项国际专家共识
Hepatobiliary Surg Nutr. 2018 Oct;7(5):353-371. doi: 10.21037/hbsn.2018.08.01.